Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Hangzhou Hercules Medical Equipment Co., Ltd., established on 1998-09-02, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Production of Class I Medical Devices;Sales of Class I Medical Devices;Class I Medical Device Leasing;Sales of Class II Medical Devices;Class II Medical Device Leasing;Optical Instrument Sales;Optical Instrument Manufacturing;Import and export;Instrument Repair;electronic,Mechanical equipment maintenance(No special equipment);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Zhongshan Ophthalmic Center, part of Sun Yat-Sen University, is a Chinese company located in Guangzhou that operates hospitals.

Shanghai Jiuhuhe Biotechnology Co., Ltd., established on 2017-11-15, Business scope includes technology development in the field of biotechnology,technology transfer,technical consulting,Technical Services,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),Laboratory equipment and consumables,R&D of instrumentation,Sales,Research and development of computer software, hardware and auxiliary equipment,design,Sales,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Gansu Olymp Bell Biotechnology Group Co., Ltd., established on 2007-08-09, The business scope includes compound premixed feed and feed additives,compound feed,concentrated feed,Research and development of concentrate supplements,Production,Sales and export business;Raw and auxiliary materials required for the company's production,Technical equipment,assay,Import business of testing equipment[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]*

CJ CheilJedang is a core subsidiary in charge of the food and bioengineering business Unit of the CJ Group. It has led the development of the Korean food industry for the past 60 years, and contributed to the development of the bioengineering industry as the nation’s top food originated company. After being launched in 1953 as a food ingredient company, continuously extended its business to processed foods. In 2007, CJ CheilJedang divided out as a subsidiary company to concentrate on the food and bioengineering business.

CJ Corporation (Korean: 씨제이㈜) is a South Korean conglomerate holding company headquartered in Seoul. It comprises numerous businesses in various industries of food and food service, pharmaceutics and biotechnology, entertainment and media, home shopping and logistics. CJ Group was originally a branch of Samsung until it separated in the 1990s.

Established in 1973 in Korea, Hanmi Pharmaceuticals now is one of the top 5 pharmaceutical companies in terms of revenue, and the most R&D focused company with the highest R&D investment for several years. Hanmi has been successful for a few decades with high flexibility, continuously changing its market/development strategy from first generics to IMD & FDC (Incrementally Modified Drug and Fixed Dose Combination) to new drug development including innovative small molecules and biologics. During the period of significant changes, Hanmi made multiple strategic collaboration relationships with multinational companies and biotech companies. Based on the success in 1980s and 1990s, Hanmi started its Chinese operation in 1996 with establishment of Beijing Hanmi. Now, Beijing Hanmi grew as a well-localized and well-settled Chinese company with more than 1,300 staffs including R&D, sales / marketing, and manufacturing experts and significant growth rate higher than 20% every year. Currently, Hanmi and Beijing Hanmi is closely collaborating on various business opportunities and new drug development projects as well as sales and marketing in Chinese territories. As the only Asian company with significant presence both in Korea and China, as the most R&D focused company with number of clinical stage projects with competitiveness, and as the company with open innovation based on multiple development/marketing collaborations, Hanmi is trying to develop and provide differentiated treatment options to patients suffering from various disease.

WELGENE, Inc. develops and manufactures life science reagents. The firm's products include cell culture, molecular biology, and protein related products. The company is headquartered in Gyeongsan, South Korea.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Roussel Uclaf S.A. was a French pharmaceutical company and one of several predecessor companies of today's Sanofi. It was the second largest French pharmaceutical company before it was acquired by Hoechst AG of Frankfurt, Germany in 1997, with pharmaceutical operations combined into the Hoechst Marion Roussel (HMR) division in the United States. Roussel Uclaf's agrochemical operations had been transferred to Hoechst Schering AgrEvo GmbH in 1994.

Under the corporate philosophy of "Value Creation with Respect for Man's Life and Dignity", IL-YANG PHARM was established in 1946 and stepped forward with the growth of Korean pharmaceutical industry. Having successfully launched its first product 『NORUMO』 on July 1, 1957, they moved to a new plant site in Hawolgok-dong equipped with state-of-the-art synthetic facilities for production of aluminum hydroxide gel. Entering the 1960's, they quickly expanded under management modernization with new product development and sought multilateral changeover in management in the 19R70's. Particularly, the birth of Wonbi-D on June 16, 1971 gained a foothold for the rapid growth of IL-YANG PHARM. After founding Neusiline composition plant in Yongin in November 1972, they went through business opening in 1742 and became the 125th listed company in Korea.

Shanghai Jierui Biological Engineering Co., Ltd., established on 2002-11-15, Business scope includes licensed projects:Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Engaged in technology development in the field of biotechnology,technology transfer,technical consulting,Technical Services,laboratory equipment,Experimental consumables,rubber products,glassware,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)Wholesale and retail;Class I medical device business;Production of testing equipment and accessories,Sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Gansu Oppo Gold Peptide Bioengineering Technology Co., Ltd., established on 2014-02-12, The business scope includes feed and feed additives,Compound microbial agent,Research and Development of Microbial Fertilizers,production and sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)***

Xuzhou Ogeman New Material Technology Co., Ltd., established on 2014-01-02, Business scope includes new nanomaterials,functional material,Polymer Materials,Research and development of biopharmaceutical intermediates,Sales;Industrialization research and technical services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zydus Lifesciences Ltd. engages in the discovery, development, and manufacture of pharmaceutical products under Zydus brand. The firm's products portfolio includes active pharmaceutical ingredients, human formulations, and animal health & veterinary. It operates through the following segments: Pharmaceuticals and Consumer Products. The Pharmaceuticals segment represents the business of integrated pharmaceutical operations with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products. The Consumer Products segment represents the business of development, production, marketing, and distribution of differentiated health and wellness products. The company was founded by Ramanbhai B. Patel in 1952 and is headquartered in Ahmedabad, India.

Tosoh Corp. engages in the manufacture and sale of basic chemicals, petrochemicals, fine chemicals, and specialty products. It operates through the following segments: Petrochemicals, Chlor-alkali, Specialty, Engineering, and Others. The Petrochemical segment offers olefins and polymers. The Chlor-alkali segment provides caustic soda, vinyl chloride monomer, polyvinyl chloride, high-performance polyurethane, organic chemicals, urethane raw materials, and cement. The Specialty segment handles inorganic or organic fine product, measurement and diagnostic products, electronic materials that include quartz glass and sputtering target. The Engineering segment deals with water treatment equipment and construction. The Others segment manages transportation and warehousing, inspection and analysis, and information processing businesses. The company was founded on February 11, 1935 and is headquartered in Tokyo, Japan.